Schubert & CO Bridge Bio Pharma, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$7.17 - $18.55 $28 - $74	-4 Reduced 12.9%	27 $0
Q4 2022 Jan 31, 2023	SELL	$6.74 - $11.52 $6 - $11	-1 Reduced 3.13%	31 $0
Q3 2022 Oct 21, 2022	BUY	$7.94 - $12.36 $127 - $197	16 Added 100.0%	32 $0
Q2 2022 Aug 01, 2022	BUY	$5.21 - $12.14 $67 - $157	13 Added 433.33%	16 $0
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $7 - $17	1 Added 50.0%	3 $0
Q4 2021 Jan 28, 2022	BUY	$11.38 - $53.41 $22 - $106	2 New	2 $0

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.